What is Milestone Pharmaceuticals Inc. Common Shares's Market Cap?

Milestone Pharmaceuticals Inc. Common Shares's Market Cap is $140.1M, based on as-reported figures from SEC (XBRL) filings.

What is Milestone Pharmaceuticals Inc. Common Shares's Enterprise Value?

Milestone Pharmaceuticals Inc. Common Shares's Enterprise Value is $28.7M, based on as-reported figures from SEC (XBRL) filings.

What is Milestone Pharmaceuticals Inc. Common Shares's EV / EBITDA?

Milestone Pharmaceuticals Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Milestone Pharmaceuticals Inc. Common Shares's Net Income (TTM)?

Milestone Pharmaceuticals Inc. Common Shares's Net Income (TTM) is -$84.0M, based on as-reported figures from SEC (XBRL) filings.

What is Milestone Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM)?

Milestone Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM) is -0.67, based on as-reported figures from SEC (XBRL) filings.

Milestone Pharmaceuticals Inc. Common Shares (MIST) Financial Statements

Milestone Pharmaceuticals Inc. Common Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG009DR4MP6

XNAS · usd

1.13▼ 0.07 (-6.25%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.20

Day's Range1.12 – 1.22

52-Week Range1.00 – 3.06

Volume1.8M

Avg Volume1.6M

Share Statistics

Shares Outstanding

Employees38

ExchangeXNAS

Listed2019-05-09

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Milestone Pharmaceuticals Inc. Common Shares (MIST)

What is Milestone Pharmaceuticals Inc. Common Shares's Market Cap?: Milestone Pharmaceuticals Inc. Common Shares's Market Cap is $140.1M, based on as-reported figures from SEC (XBRL) filings.
What is Milestone Pharmaceuticals Inc. Common Shares's Enterprise Value?: Milestone Pharmaceuticals Inc. Common Shares's Enterprise Value is $28.7M, based on as-reported figures from SEC (XBRL) filings.
What is Milestone Pharmaceuticals Inc. Common Shares's EV / EBITDA?: Milestone Pharmaceuticals Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Milestone Pharmaceuticals Inc. Common Shares's Net Income (TTM)?: Milestone Pharmaceuticals Inc. Common Shares's Net Income (TTM) is -$84.0M, based on as-reported figures from SEC (XBRL) filings.
What is Milestone Pharmaceuticals Inc. Common Shares's EBITDA?: Milestone Pharmaceuticals Inc. Common Shares's EBITDA is -$78.2M, based on as-reported figures from SEC (XBRL) filings.
What is Milestone Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM)?: Milestone Pharmaceuticals Inc. Common Shares's Diluted EPS (TTM) is -0.67, based on as-reported figures from SEC (XBRL) filings.
What is Milestone Pharmaceuticals Inc. Common Shares's Net Debt?: Milestone Pharmaceuticals Inc. Common Shares's Net Debt is -$111.4M, based on as-reported figures from SEC (XBRL) filings.